Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

KESIMPTA 20 MG / 0.4 ML

OFATUMUMAB : 20 MG / 0.4 ML · DIN 02511355 · NOVARTIS PHARMACEUTICALS CANADA INC

Health Canada status: MARKETED

KESIMPTA 20 MG / 0.4 ML SOLUTION - DIN 02511355
KESIMPTA — DIN 02511355. Product photograph held by Nexara Health.

What is KESIMPTA?

KESIMPTA 20 MG / 0.4 ML contains OFATUMUMAB : 20 MG / 0.4 ML. It is listed in the Health Canada Drug Product Database under DIN 02511355, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as SOLUTION for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 08-Apr-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02511355
Brand nameKESIMPTA
Generic / active ingredientOFATUMUMAB : 20 MG / 0.4 ML
ManufacturerNOVARTIS PHARMACEUTICALS CANADA INC
Strength20 MG / 0.4 ML
Dosage formSOLUTION
Route of administrationSUBCUTANEOUS
ScheduleSchedule D
ATC codeL04AG12 OFATUMUMAB
AHFS class10:00.00
BiosimilarNo
Health Canada statusMARKETED
Status date08-Apr-2021
Original market date2021-06-25 00:00:00

What can be used instead?

Other Canadian products sharing ATC code L04AG12 OFATUMUMAB. 1 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
KESIMPTA20 MG / 0.4 MLSOLUTIONNOVARTIS PHARMACEUTICALS CANADA INCAPPROVEDDIN 02511363

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for KESIMPTA

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for KESIMPTA

Health Canada Drug Product Database (DPD), DIN 02511355. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.